Abstract
Arginase constrains endothelial nitric oxide synthase activity by competing for the common substrate, L -Arginine. We have recently shown that inducible nitric oxide synthase (NOS2) S-nitrosates and activates arginase 1 (Arg1) leading to age-associated vascular dysfunction. Here, we demonstrate that a direct interaction of Arg1 with NOS2 is necessary for its S-nitrosation. The specific domain of NOS2 that mediates this interaction is identified. Disruption of this interaction in human aortic endothelial cells prevents Arg1 S-nitrosation and activation. Thus, disruption of NOS2-Arg1 interaction may represent a therapeutic strategy to attenuate age related vascular endothelial dysfunction.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aging / pathology
-
Animals
-
Aorta / cytology
-
Aorta / drug effects
-
Aorta / enzymology
-
Arginase / metabolism*
-
Cell Line
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / enzymology
-
Enzyme Assays
-
Humans
-
Immunoprecipitation
-
Interferon-gamma / pharmacology
-
Interferon-gamma / physiology
-
Lipopolysaccharides / pharmacology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Nitrates / metabolism*
-
Nitric Oxide Synthase Type II / chemistry
-
Nitric Oxide Synthase Type II / genetics
-
Nitric Oxide Synthase Type II / metabolism*
-
Nitrosation
-
Peptide Fragments / metabolism
-
Protein Binding
-
Protein Structure, Tertiary
Substances
-
Lipopolysaccharides
-
Nitrates
-
Peptide Fragments
-
Interferon-gamma
-
Nitric Oxide Synthase Type II
-
Arginase